Skip to main content
. 2013 Feb 1;4:1–9. doi: 10.2147/JBM.S33906

Table 3.

Outcomes during induction treatment

Outcomes Placebo Ciprofloxacin Total OR 95% CI P-value



n % n % n %
Total patients 52 47.3 58 52.7 110 100
Induction outcome
 Complete remission 39 75.0 40 69.0 79 71.8
 Induction failures 13 25.0 18 31.0 31 28.2 1.35a 0.58–3.12 0.48#
  Death 3 5.8 11 18.9 14 12.8 3.57a 0.92–13.80 0.05#
  Abandonment 7 13.5 3 5.2 10 9.0 0.42a 0.10–1.73 0.32##
  Resistant disease 3 5.8 4 6.9 7 6.4 1.3a 0.27–6.19 1.00##
Fever > 38.5°C
 Never 35 67.3 29 50.0 64 58.2
 Ever 17 32.7 29 50.0 46 41.8 2.06b 0.95–4.47 0.07#
Clinical sepsis
 Never 32 61.5 29 50.0 61 55.5
 Ever 20 38.5 29 50.0 49 44.5 1.60b 0.75–3.42 0.22#

Notes:

a

ORs for any induction failure and specific induction failures (CR is taken as the reference outcome category);

b

ORs for event of fever and clinical sepsis (Never is taken as the reference outcome category);

#

Chi-square test;

##

Fisher’s exact test.

Abbreviations: OR, odds ratio (ciprofloxacin group relative to placebo group); CI, confidence interval.